Blake Photo Time-Line

BRMH EMERGENCY DEPARTMENT 17000 Medical Center Dr Baton Rouge LA 70816

Grondin, Blake John MRN: 12051461, DOB: 2/14/2020, Sex: M Acct #: 72011877124 Adm: 12/5/2020

12/05/2020 - ED in O'Neal - Emergency Dept. (continued)

ED Notes (continued)

Labs

COVID-19 Rapid Screening [565865211] (Final result)

Electronically signed by: Michelle E Carley, MD on 12/05/20 1748

Status: Completed

Ordering user: Michelle E Carley, MD 12/05/20 1748

Ordering provider: Michelle E Carley, MD

Authorized by: Michelle E Carley, MD

Ordering mode: Standard

Frequency: STAT STAT 12/05/20 1748 - 1 occurrence

Class: Unit Collect

Quantity: 1

Lab status: Final result

Instance released by: Michelle E Carley, MD (auto-released) 12/5/2020 5:48 PM

Questionnaire

Question

Answer

Is the patient symptomatic?

Yes

Specimen Information ID

Type

Source

Collected By

9605007590:2 Nasal Swab

Nasal Swab

Lindsay M. Gauthreaux, LPN 12/05/20 1803

COVID-19 Rapid Screening [565865211]

Resulted: 12/05/20 1844, Result status: Final result

Ordering provider: Michelle E Carley, MD 12/05/20 1748

Order status: Completed

Filed by: Edi, Soft Lab Interface 12/05/20 1844

Collected by: Lindsay M. Gauthreaux, LPN 12/05/20 1803

Resulting lab: OCHSNER MEDICAL CENTER - BATON ROUGE

Component Components

Value

Reference Range Flag

Lab

SARS-CoV-2 RNA, Amplification, Qual

Negative

Negative

—

BRLB

Comment: This test utilizes isothermal nucleic acid amplification technology to detect the SARS-CoV-2 RdRp nucleic acid segment. The analytical sensitivity (limit of detection) is 125 genome equivalents/mL. A POSITIVE result implies infection with the SARS-CoV-2 virus; the patient is presumed to be contagious. A NEGATIVE result means that SARS-CoV-2 nucleic acids are not present above the limit of detection. A NEGATIVE result should be treated as presumptive. It does not rule out the possibility of COVID-19 and should not be the sole basis for treatment decisions. If COVID-19 is strongly suspected based on clinical and exposure history, re-testing using an alternate molecular assay should be considered. This test is only for use under the Food and Drug

Administration s Emergency Use Authorization (EUA). Commercial kits are provided by Abbott Diagnostics. Performance characteristics of the EUA have been independently verified by Ochsner Medical Center Department o f Pathology and Laboratory Medicine. _________________________________________________________________ The ID NOW COVID-19 Letter of Authorization, along with the authorized Fact Sheet for Healthcare Providers, the authorized Fact Sheet for Patients, and authorized labeling are available on the FDA website: www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm

Testing Performed By

Lab - Abbreviation Name

Director

Address

Valid Date Range

Generated on 7/19/22 2:38 PM

Page 48